• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根据控制性卵巢刺激方案调整抗逆转录病毒治疗实验室的关键绩效指标。

Adjusting key performance indicators in ART laboratories according to controlled ovarian stimulation protocol.

作者信息

Chen Wei, Cheng Shiyuan, Liu Yan, Wu Zhaoting, Zhang Fuli, Huang Xianju, Yao Guidong, Song Wenyan, Jin Haixia

机构信息

Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Henan Key Laboratory of Reproduction and Genetics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

出版信息

Front Physiol. 2025 Aug 12;16:1632623. doi: 10.3389/fphys.2025.1632623. eCollection 2025.

DOI:10.3389/fphys.2025.1632623
PMID:40873757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12378807/
Abstract

BACKGROUND

Reliable key performance indicators (KPIs) have been proposed to facilitate the quality management of embryo laboratories. However, the effects of controlled ovarian stimulation (COS) protocols on KPIs have not been adequately explored. This study aims to assess the variation in KPIs across four different COS protocols.

METHODS

We retrospectively analyzed 51,728 IVF/ICSI cycles in our center between 2014 and 2022. They were divided into four groups based on COS protocols: follicular phase long-acting (FPL) GnRH-a long, luteal phase short-acting (LPS) GnRH-a long, GnRH-ant, and micro-stimulation protocol groups. Several KPIs were compared across the four groups, and the results were validated in three age bands (<35 years, 35-38 years, and >38 years). Multivariable regression analysis was conducted to assess the effect of COS protocols on KPIs.

RESULTS

  1. Significant differences were observed among the four groups in total blastocyst development rate (BLR) (56.2%, 54.1%, 49.7%, 29.5%, p < 0.001), total good blastocyst development rate (GBLR) (26.8%, 30.4%, 21.1%, 13.1%, p < 0.001), and implantation rate (46.6%, 30.7%, 24.2%, 13.1%, p < 0.001). 2) The LPS GnRH-a group showed a higher total GBLR (30.4%, 26.8%, p < 0.001) but a lower implantation rate compared to the FPL GnRH-a group (30.7%, 46.6%, p < 0.001). 3) Significant differences in KPIs were observed across all age groups, with the largest differences seen in women under 35 years 4) Multivariate logistic regression analysis revealed that these KPIs were significantly associated with the COS protocol.

CONCLUSION

COS protocols significantly impact KPIs, suggesting that explore reliable KPIs according to treatment protocols could better evaluate the laboratory efficacy and provide a theoretical basis for personalized strategies for patients.

摘要

背景

已提出可靠的关键绩效指标(KPI)以促进胚胎实验室的质量管理。然而,控制性卵巢刺激(COS)方案对KPI的影响尚未得到充分探讨。本研究旨在评估四种不同COS方案下KPI的差异。

方法

我们回顾性分析了2014年至2022年期间本中心的51728个IVF/ICSI周期。根据COS方案将它们分为四组:卵泡期长效(FPL)GnRH-a长方案、黄体期短效(LPS)GnRH-a长方案、GnRH拮抗剂方案和微刺激方案组。比较了四组之间的几个KPI,并在三个年龄组(<35岁、35-38岁和>38岁)中验证了结果。进行多变量回归分析以评估COS方案对KPI的影响。

结果

1)四组在总囊胚发育率(BLR)(56.2%、54.1%、49.7%、29.5%,p<0.001)、总优质囊胚发育率(GBLR)(26.8%、30.4%、21.1%、13.1%,p<0.001)和着床率(46.6%、30.7%、24.2%、13.1%,p<0.001)方面存在显著差异。2)与FPL GnRH-a组相比,LPS GnRH-a组的总GBLR较高(30.4%对26.8%,p<0.001),但着床率较低(30.7%对46.6%,p<0.001)。3)所有年龄组的KPI均存在显著差异,35岁以下女性的差异最大。4)多变量逻辑回归分析显示,这些KPI与COS方案显著相关。

结论

COS方案对KPI有显著影响,这表明根据治疗方案探索可靠的KPI可以更好地评估实验室效率,并为患者的个性化策略提供理论依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/023804852764/fphys-16-1632623-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/2f66cbde476e/fphys-16-1632623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/a7f20e208831/fphys-16-1632623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/f065fd7588bb/fphys-16-1632623-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/d7f6f07adbe5/fphys-16-1632623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/d7c5b48a22f8/fphys-16-1632623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/023804852764/fphys-16-1632623-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/2f66cbde476e/fphys-16-1632623-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/a7f20e208831/fphys-16-1632623-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/f065fd7588bb/fphys-16-1632623-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/d7f6f07adbe5/fphys-16-1632623-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/d7c5b48a22f8/fphys-16-1632623-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d4a8/12378807/023804852764/fphys-16-1632623-g005.jpg

相似文献

1
Adjusting key performance indicators in ART laboratories according to controlled ovarian stimulation protocol.根据控制性卵巢刺激方案调整抗逆转录病毒治疗实验室的关键绩效指标。
Front Physiol. 2025 Aug 12;16:1632623. doi: 10.3389/fphys.2025.1632623. eCollection 2025.
2
Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis.辅助生殖的控制性卵巢刺激方案:一项网状荟萃分析。
Cochrane Database Syst Rev. 2025 Jul 1;7(7):CD012586. doi: 10.1002/14651858.CD012586.pub2.
3
Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.在拮抗剂辅助生殖技术中,促性腺激素释放激素激动剂与绒毛膜促性腺激素用于卵母细胞触发的比较
Cochrane Database Syst Rev. 2014 Oct 31;2014(10):CD008046. doi: 10.1002/14651858.CD008046.pub4.
4
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.口服药物,包括枸橼酸氯米芬或芳香化酶抑制剂与促性腺激素联合用于接受体外受精的女性的控制性卵巢刺激。
Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3.
5
In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.多囊卵巢综合征不孕妇女在辅助生殖过程中的体外成熟。
Cochrane Database Syst Rev. 2025 Feb 6;2(2):CD006606. doi: 10.1002/14651858.CD006606.pub5.
6
Luteal phase support for assisted reproduction cycles.辅助生殖周期的黄体期支持。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD009154. doi: 10.1002/14651858.CD009154.pub2.
7
What is the optimal GnRH antagonist protocol for ovarian stimulation during ART treatment? A systematic review and network meta-analysis.ART 治疗中卵巢刺激时最佳 GnRH 拮抗剂方案是什么?系统评价和网络荟萃分析。
Hum Reprod Update. 2023 May 2;29(3):307-326. doi: 10.1093/humupd/dmac040.
8
The clinical impact of oligozoospermia in oocyte donation ICSI cycles using preimplantation genetic test for aneuploidy.在使用植入前非整倍体基因检测的卵母细胞捐赠ICSI周期中,少精子症的临床影响。
Hum Reprod. 2025 May 13. doi: 10.1093/humrep/deaf080.
9
Flexible progestin-primed ovarian stimulation versus a GnRH antagonist protocol in predicted suboptimal responders undergoing freeze-all cycles: a randomized non-inferiority trial.灵活孕激素预处理的卵巢刺激方案与GnRH拮抗剂方案用于预测的低反应者进行全胚冷冻周期的比较:一项随机非劣效性试验
Hum Reprod. 2025 Feb 1;40(2):319-327. doi: 10.1093/humrep/deae286.
10
One-year cumulative live birth rate associated with the number of oocytes in ovarian stimulation with follitropin delta: a pooled analysis of four randomized controlled trials.与使用注射用重组促卵泡素δ进行卵巢刺激时的卵母细胞数量相关的一年累积活产率:四项随机对照试验的汇总分析
Hum Reprod. 2025 Aug 1;40(8):1526-1534. doi: 10.1093/humrep/deaf111.

本文引用的文献

1
Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.辅助生殖中用于垂体抑制的促性腺激素释放激素激动剂方案。
Cochrane Database Syst Rev. 2025 Jan 9;1(1):CD006919. doi: 10.1002/14651858.CD006919.pub5.
2
Effects of total gonadotropin dose on embryo quality and clinical outcomes with AMH stratification in IVF cycles: a retrospective analysis of 12,588 patients.促性腺激素总剂量对 AMH 分层的 IVF 周期中胚胎质量和临床结局的影响:对 12588 例患者的回顾性分析。
Eur J Med Res. 2024 Mar 12;29(1):167. doi: 10.1186/s40001-024-01768-w.
3
Effects of Low Luteinizing Hormone Serum Levels on Oocyte Retrieval, Fertilization Rate, and Embryo Quality during Controlled Ovarian Stimulation: Results from a Prospective Cohort Analysis.
低黄体生成素血清水平对控制性卵巢刺激中卵母细胞采集、受精率和胚胎质量的影响:一项前瞻性队列分析的结果。
Gynecol Obstet Invest. 2024;89(1):50-58. doi: 10.1159/000534860. Epub 2023 Oct 30.
4
Clinical and laboratory key performance indicators in IVF: A consensus between the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) and the Italian Society of Embryology, Reproduction and Research (SIERR).辅助生殖技术中临床和实验室关键绩效指标:意大利生育与不育学会(SIFES-MR)和意大利胚胎学、生殖与研究学会(SIERR)的共识
J Assist Reprod Genet. 2023 Jun;40(6):1479-1494. doi: 10.1007/s10815-023-02792-1. Epub 2023 Apr 24.
5
The effect of large follicle puncture and aspiration on the outcomes of IVF-ET in patients with asynchronized follicles under the long GnRH-a protocol: a retrospective cohort study.长 GnRH-a 方案下单发大卵泡穿刺抽吸对卵泡不同步患者 IVF-ET 结局的影响:一项回顾性队列研究。
BMC Pregnancy Childbirth. 2023 Jan 25;23(1):64. doi: 10.1186/s12884-023-05397-9.
6
Infertility prevalence and the methods of estimation from 1990 to 2021: a systematic review and meta-analysis.1990年至2021年不孕症患病率及其估计方法:一项系统评价和荟萃分析。
Hum Reprod Open. 2022 Nov 12;2022(4):hoac051. doi: 10.1093/hropen/hoac051. eCollection 2022.
7
Ovarian stimulation in IVF couples with severe male factor infertility: GnRH antagonist versus long GnRH agonist.体外受精中严重男性因素不育患者的卵巢刺激:促性腺激素释放激素拮抗剂与长效促性腺激素释放激素激动剂。
Front Endocrinol (Lausanne). 2022 Oct 7;13:1037220. doi: 10.3389/fendo.2022.1037220. eCollection 2022.
8
Fine-tuning IVF laboratory key performance indicators of the Vienna consensus according to female age.根据女性年龄调整 IVF 实验室关键绩效指标的维也纳共识。
J Assist Reprod Genet. 2022 Apr;39(4):945-952. doi: 10.1007/s10815-022-02468-2. Epub 2022 Mar 26.
9
More blastocysts are produced from fewer oocytes in ICSI  compared to IVF - results from a sibling oocytes study and definition of a new key performance indicator.与 IVF 相比,ICSI 会从较少的卵母细胞中产生更多的囊胚——来自同胞卵母细胞研究的结果和新关键绩效指标的定义。
Reprod Biol Endocrinol. 2021 Jul 26;19(1):116. doi: 10.1186/s12958-021-00804-2.
10
Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study.根据 POSEIDON 标准,低预后患者中 GnRH-A 与 PPOS 累积活产率的比较:一项队列研究。
Front Endocrinol (Lausanne). 2021 Jun 21;12:644456. doi: 10.3389/fendo.2021.644456. eCollection 2021.